WeVote
Log In

Bill

Bill

SB 337

Revises provisions relating to opioids. (BDR 40-204)

2025 Regular Session Introduced by Roberta Lange

Nevada SB 337 revises opioid provisions through amendments, referred to Finance Committee, with unclear final status as of June 2025.

(No further action taken.)
0
WeVote Research Nonpartisan
Bill Summary · SB 337

Legislative bill overview

SB 337 revises Nevada's opioid-related provisions, though the specific amendments are not detailed in the available legislative record. The bill has progressed through committee review and amendment processes, most recently being referred to the Finance Committee in April 2025.

Why is this important

Opioid policy directly affects public health outcomes, addiction treatment accessibility, and healthcare costs in Nevada. Changes to opioid regulations can influence prescribing practices, medication availability, and resources for substance abuse programs.

Potential points of contention

  • Lack of transparency: The specific amendments (Amendment No. 464) are not publicly summarized in the available record, making it difficult to assess what stakeholders support or oppose
  • Finance Committee referral: The bill's referral to Finance rather than remaining solely in Health suggests cost implications that may create budget-related disagreements
  • Incomplete legislative status: The bill shows no action since June 3, 2025, indicating it may have stalled or died in committee, leaving its final intent unclear

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.